Who is the study sponsor?
Nicole Bragg2025-10-16T10:40:54-07:00Teva Branded Pharmaceutical Products LLC
Teva Branded Pharmaceutical Products LLC
A clinical trial is a study that helps researchers determine if a new treatment is safe and effective. All medications must go through multiple phases of clinical trials before they can be approved for the public.
A placebo is an inactive substance with no therapeutic effect that is used to help determine whether results are due to the study drug.
Yes. TEV-53408 has been tested in healthy people and in a small number of patients with celiac disease in previous studies, and the drug was shown to be safe and well-tolerated.
TEV-53408 will be given as a single injection under the skin in the abdomen (belly area).
The study drug, TEV-53408, is an antibody designed to block interleukin-15 (IL-15). In celiac disease patients, gluten consumption results in the production of IL-15 which triggers intestinal inflammation, leading to destruction of intestinal cells. The goal of TEV-53408 is to help reduce intestinal inflammation and tissue damage associated with celiac disease.